Cubist Systematic Strategies, LLC Crinetics Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$15.73 - $23.6 $725,027 - $1.09 Million	46,092 Added 4190.18%	47,192 $850,000
Q1 2023 May 15, 2023	BUY	$15.31 - $21.1 $16,841 - $23,210	1,100 New	1,100 $17,000
Q3 2022 Nov 14, 2022	SELL	$18.11 - $22.37 $118,674 - $146,590	-6,553 Reduced 77.29%	1,925 $38,000
Q2 2022 Aug 15, 2022	BUY	$16.49 - $27.64 $57,764 - $96,822	3,503 Added 70.41%	8,478 $158,000
Q1 2022 May 16, 2022	BUY	$17.15 - $28.31 $57,418 - $94,781	3,348 Added 205.78%	4,975 $109,000
Q4 2021 Feb 14, 2022	SELL	$19.35 - $28.41 $373,667 - $548,625	-19,311 Reduced 92.23%	1,627 $46,000
Q3 2021 Nov 15, 2021	BUY	$16.88 - $25.23 $146,130 - $218,416	8,657 Added 70.49%	20,938 $441,000
Q2 2021 Aug 16, 2021	BUY	$15.9 - $21.15 $194,997 - $259,383	12,264 Added 72141.18%	12,281 $231,000
Q1 2021 May 17, 2021	SELL	$13.3 - $17.55 $15,308 - $20,200	-1,151 Reduced 98.54%	17 $0
Q4 2020 Feb 16, 2021	BUY	$12.08 - $17.46 $14,109 - $20,393	1,168 New	1,168 $16,000
Q3 2020 Nov 16, 2020	SELL	$13.62 - $17.66 $20,198 - $26,189	-1,483 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.04 - $23.23 $19,338 - $34,450	1,483 New	1,483 $26,000
Q1 2020 May 15, 2020	SELL	$11.52 - $26.46 $54,144 - $124,362	-4,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.24 - $25.09 $44,531 - $73,312	2,922 Added 164.34%	4,700 $118,000
Q3 2019 Nov 14, 2019	BUY	$14.91 - $25.01 $26,509 - $44,467	1,778 New	1,778 $27,000

241

79.5M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.9B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.